BioNTech to build first mRNA manufacturing facility in Singapore

| | Berlin
  • 0

BioNTech to build first mRNA manufacturing facility in Singapore

Tuesday, 11 May 2021 | IANS | Berlin

German biotechnology company BioNTech on Monday announced plans to expand its global footprint to Asia by building its first mRNA manufacturing facility in Singapore.

The Covid vaccine maker will establish its regional headquarters for Southeast Asia in Singapore, later this year, it said in a statement. The facility will be operational as early as 2023, it added.

The fully integrated mRNA manufacturing facility will provide regional and global supply capacity of BioNTech’s growing pipeline of mRNA-based product candidates. It will be equipped to produce a range of novel mRNA vaccines and therapeutics for infectious diseases and cancer.

               

State Editions

60 lakh got jab in Capital: Atishi

14 June 2021 | Staff Reporter | Delhi

Unlock 3.0: Cops to keep eye on violators

14 June 2021 | Staff Reporter | Delhi

255 Covid cases

14 June 2021 | Staff Reporter | Delhi

Target to set up 1,213 plants of O2 across India: Pradhan

14 June 2021 | Staff Reporter | Delhi

AAP accuses East Civic body of corruption

14 June 2021 | Staff Reporter | Delhi

Sunday Edition

Talktime : ‘I have said no to many films initially’

13 June 2021 | MUSBA HASHMI | Sunday Pioneer

Be smart, keep cool

13 June 2021 | Shalini Saksena | Sunday Pioneer

‘Acting is my passion, love being part of this magical world’

13 June 2021 | Shalini Saksena | Sunday Pioneer

WeeklyNatter

13 June 2021 | PNS | Sunday Pioneer

World Wide Web of Artificial Intelligence

13 June 2021 | Akshat Tyagi | Agenda

The vaccine solution

13 June 2021 | Sonu Shivdasani | Agenda